Comorbidities in chronic neuropathic pain

Pain Medicine

Volumn 5, Issue SUPPL. 1, 2004, Pages

  Nicholson, Bruce ^a   Verma, Sunil ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Anxiety; Chronic pain; Comorbidities; Depressed mood; Neuropathic pain; Sleep disturbances

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; CARBAMAZEPINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DULOXETINE; ESCITALOPRAM; ESTAZOLAM; FENTANYL; FLUOXETINE; FLURAZEPAM; FLUVOXAMINE; GABAPENTIN; IMIPRAMINE; MORPHINE; NORTRIPTYLINE; OXCARBAZEPINE; PAROXETINE; PREGABALIN; REBOXETINE; SERTRALINE; TEMAZEPAM; TRAMADOL; TRIAZOLAM; UNINDEXED DRUG; VENLAFAXINE; ZALEPLON; ZOLPIDEM; ZOPICLONE;

AMNESIA; ANXIETY DISORDER; APPETITE DISORDER; BODY WEIGHT DISORDER; CHRONIC PAIN; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; COMPLEX REGIONAL PAIN SYNDROME TYPE II; DELUSION; DEPRESSION; DIABETIC NEUROPATHY; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; EXPERIENCE; FEMALE; HALLUCINATION; HEART DISEASE; HUMAN; INSOMNIA; MALE; MANIA; MEDICAL INFORMATION; MEDICAL RESEARCH; MOOD DISORDER; MUSCLE STIFFNESS; MYALGIA; NAUSEA; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; OBSESSIVE COMPULSIVE DISORDER; ORTHOSTATIC HYPERTENSION; PAIN ASSESSMENT; PAIN THRESHOLD; PHYSICIAN; POSTHERPETIC NEURALGIA; PSYCHOSEXUAL DISORDER; QUALITATIVE ANALYSIS; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; RELAXATION TRAINING; REVIEW; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP THERAPY; SOMNOLENCE; SPINAL CORD INJURY; SUICIDE; SYMPTOMATOLOGY; TEAMWORK; TREATMENT OUTCOME; TRIGEMINUS NEURALGIA; XEROSTOMIA;

ANXIETY DISORDERS; CHRONIC DISEASE; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; NEURALGIA; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PSYCHOTROPIC DRUGS; RELAXATION TECHNIQUES; SLEEP DISORDERS;

EID: 1642566659     PISSN: 15262375     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2004.04019.x     Document Type: Review

References (106)

1. Widerström-Noga EG, Felipe-Cuervo E, Yezierski RP. Chronic pain after spinal injury: Interference with sleep and daily activities. Arch Phys Med Rehabil 2001;82:1571-7.
2. Clecland CS, Ryon KM. Pain assessment: Global use of the Brief Pain Inventory, Ann Acad Med Singapore 1994;23:129-38.
3. Breitbart W, McDonald MV, Rosenfeld B, Passik SD, Hewitt D, Thaler H, Portenoy RK. Pain in ambulatory AIDS patients. I: Pain characteristics and medical correlates. Pain 1996;68:315-21.
4. Moldofsky H, Scarisbrick P, England R, Smythe H. Musculoskeletal symptoms and non-REM sleep disturbance in patients with "fIbrositis syAdrome" and healthy subjects. Psychosom Med 1975; 37: 341-51.
5. Smith MT, Perlis ML, Smith MS, Giles DE, Carmody TP. Sleep quality and presleep arousal in chronic pain. J Behav Med 2000;23:1-13.
6. Fishbain DA. Approaches to treatment decisions for psychiatric comorbidity in the management of the chronic pain patient. Med Clin North Am 1999;83:737-60, vii.
7. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Chronic pain-associated depression: Antecedent or consequence of chronic pain? A review. Clin J Pain 1997;13:116-37.
8. Romano JM, Turner JA. Chronic pain and depression: Does the evidence support a relationship? Psychol Bull 1985;97:18-34.
9. Gallagher RM, Rauh V, Haugh LD, Milhous R, Callas PW, Langelier R, McClallen JM, Frymoyer J. Determinants of return-to-work among low back pain patients. Pain 1989;39:55-67.
10. Morin CM, Gibson D, Wade J. Self-reported sleep and mood disturbance in chronic pain patients. Clin J Pain 1998;14:311-14.
11. Moldofsky H, Scarisbrick P. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med 1976;38: 35-44.
12. Atkinson JH, Ancoli-Israel S, Slater MA, Garfin SR, Gillin JC. Subjective sleep disturbance in chronic back pain. Clin J Pain 1988;4:225-32.
13. Haythornthwaite JA, Hegel MT, Kerns RD. Development of a sleep diary for chronic pain patients. J Pain Symptom Manage 1991;6:65-72.
14. Magni G, Caldieron C, Rigatti-Luchini S, Merskey H. Chronic musculoskeletal pain and depressive symptoms in the general population. An analysis of the 1st National Health and Nutrition Examination Survey data. Pain 1990;43:299-307.
15. Gallagher RM, Verma S. Managing pain and comorbid depression: A public health challenge. Semin Clin Neuropsychiatry 1999;4:203-20.
16. Banks SM, Kerns RD. Explaining high rates of depression in chronic pain: A diathesis-stress framework. Psychol Bull 1996;119:95-110.
17. Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 2002;18:350-4.
18. Mauskopf J, Austin R, Dix L, Berzon R. The Nottingham Health Profile as a measure of quality of life in zoster patients: Convergent and discriminant validity. Qual Life Res 1994;3:431-5.
19. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: Epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000;47:123-8.
20. Benbow SJ, Wallymahmed ME, MacFarlane IA. Diabetic peripheral neuropathy and quality of life. QJM 1998;91:733-7.
21. Zakrzewska JM, Patsalos PN. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia. Pain 2002;95:259-66.
22. International Association for the Study of Pain. Complex regional pain syndromes (CRPS). In: Merskey H, Bogduk N, editors. Classification of chronic pain. Seattle: IASP Press, 1994:40-3.
23. Putzke JD, Richards JS, Hicken BL, DeVivo MJ. Interference due to pain following spinal cord injury: Important predictors and impact on quality of life. Pain 2002;100:231-42.
24. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
25. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
26. Beck AT, Beamesderfer A. Assessment of depression: The depression inventory. Mod Probl Pharmacopsychiatry 1974;7:151-69.
27. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473-83.
28. Hunt SM, McKenna SP, McEwen J, Backett EM, Williams J, Papp E. A quantitative approach to perceived health status: A validation study. J Epidemiol Community Health 1980;34:281-6.
29. Rogers WH, Wittink HM, Ashburn MA, Cynn D, Carr DB. Using the ΑTOPS," an outcomes instrument for multidisciplinary outpatient pain treatment. Pain Med 2000;1:55-67.
30. Ahearn EP. The use of visual analog scales in mood disorders: A critical review. J Psychiatr Res 1997;31:569-79.
31. Cleeland CS. The Brief Pain Inventory, a measure of cancer pain and its impact. Quality of Life News Letter 2003.
32. Kerns RD, Finn P, Haythornthwaite J. Self-monitored pain intensity: Psychometric properties and clinical utility. J Behav Med 1988;11:71-82.
33. Follick MJ, Ahern DK, Laser-Wolston N. Evaluation of a daily activity diary for chronic pain patients. Pain 1984;19:373-82.
34. Dohrenwend BR, Raphael KG, Marbach JJ, Gallagher RM. Why is depression comorbid with chronic myofascial face pain? A family study test of alternative hypotheses. Pain 1999;83:183-92.
35. Haythornthwaite JA, Benrud-Larson LM. Psychological aspects of neuropathic pain. Clin J Pain 2000;16(suppl):S101-5.
36. Holzberg AD, Robinson ME, Geisser ME, Gremillion HA. The effects of depression and chronic pain on psychosocial and physical functioning. Clin J Pain 1996;12:118-25.
37. Keefe FJ, Wilkins RH, Cook WA Jr, Crisson JE, Muhlbaier LH. Depression, pain, and pain behavior. J Consult Clin Psychol 1986;54:665-9.
38. Krause SJ, Wiener RL, Tait RC. Depression and pain behavior in patients with chronic pain. Clin J Pain 1994;10:122-7.
39. Mossey JM, Gallagher RM, Tirumalasetti F. The effects of pain and depression on physical functioning in elderly residents of a continuing care retirement community. Pain Med 2000;1:340-50.
40. Mossey JM, Gallagher RM. (220) Evaluation of the effects of pain and depression on the physical functioning of continuing care retirement community residents: Implications for the treatment of pain in older individuals [abstract]. Pain Med 2001;2:247-8.
41. Gallagher RM, Mossey J. Inadequate pain care for elders: The need for a primary care-pain medicine community collaboration [abstract]. Pain Med 2002;3:180.
42. Gallagher RM, Verma S. Treatment and rehabilitation of chronic orthopedic pain syndromes. In: Stoudemire A, Fogel B, Greenblatt D, editors. Psychiatric care of the medical patient. New York: Oxford; 1999.
43. Gallagher RM, Moore P, Chernoff I. The reliability of depression diagnosis in chronic low back pain. A pilot study. Gen Hosp Psychiatry 1995;17:399-413.
44. Bruns D, Disorbio JM, Hanks R. Chronic nonmalignant pain and violent behavior. Curr Pain Headache Rep 2003;7:127-32.
45. Fava M, Rosenbaum JF. Anger attacks in patients with depression. J Clin Psychiatry 1999;60(suppl 15):21-4.
46. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Chronic pain disability exaggeration/malingering and submaximal effort research. Clin J Pain 1999;15:244-74.
47. Kupfer DJ. Long-term treatment of depression. J Clin Psychiatry 1991;52(suppl):28-34.
48. Dvorak J, Gauchat MH, Valach L. The outcome of surgery for lumbar disc herniation. I. A 4-17 years' follow-up with emphasis on somatic aspects. Spine 1988;13:1418-22.
49. Flor H, Fydrich T, Turk DC. Efficacy of multidisciplinary pain treatment centers: A meta-analytic review. Pain 1992;49:221-30.
50. Caudill M, Schnable R, Zuttermeister P, Benson H, Friedman R. Decreased clinic use by chronic pain patients: Response to behavioral medicine intervention. Clin J Pain 1991;7:305-10.
51. Insomnia: Assessment and management in primary care. Sleep 1999;22(suppl 2):S402-8.
52. Morin CM, Kowatch RA, Wade JB. Behavioral management of sleep disturbances secondary to chronic pain. J Behav Ther Exp Psychiatry 1989;20:295-302.
53. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-6.
54. Kvinesdal B, Molin J, Frøland A, Gram LF. Imipramine treatment of painful diabetic neuropathy. JAMA 1984;251:1727-30.
55. Sindrup SH, Ejlertsen B, Frøland A, Sindrup EH, Brøsen E, Gram LF. Imipramine treatment in diabetic neuropathy: Relief of subjective symptoms without changes in peripheral and autonomic nerve function. Eur J Clin Pharmacol 1989;37:151-3.
56. Max MB, Culnane M, Schafer SC, Gracely RH, Walther DJ, Smoller B, Dubner R. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987;37: 589-96.
57. Sindrup SH, Gram LF, Skjold T, Grodum E, Brosen K, Beck-Nielsen H. Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. Br J Clin Pharmacol 1990;30:683-91.
58. Sharpley AL, Cowen PJ. Effect of pharmacologic treatments on the sleep of depressed patients. Biol Psychiatry 1995;37:85-98.
59. Sindrup SH, Gram LF, Brøsen K, Eshøj O, Mogensen EF. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990;42:135-44.
60. Block BM, Wu CL. Pain and sleep. Int J Pain Med Palliat Care 2001;1:56-61.
61. Sammaritano, M, Sherwin A. Effect of anticonvulsants on sleep. Neurology 2000;54(suppl 1):S16-24.
62. Mellick GA, Mellick LB. Reflex sympathetic dystrophy treated with gabapentin. Arch Phys Med Rehabil 1997;78:98-105.
63. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA 1998;280:1831-6.
64. Rice AS, Maton S. Gabapentin in postherpetic neuralgia: A randomised, double blind, placebo controlled study. Pain 2001;94:215-24.
65. Orr KG, Mostert J, Castle DJ. Mania associated with codeine and paracetamol. Aust N Z J Psychiatry 1998;32:586-8.
66. Chokroverty S. Diagnosis and treatment of sleep disorders caused by co-morbid disease. Neurology 2000;54(suppl 1):S8-15.
67. Montplaisir J. Treatment of primary insomnia. CMAJ 2000;163:389-91.
68. Verma S, Gallagher RM. The psychopharmacologic treatment of depression and anxiety in the context of chronic pain. Curr Pain Headache Rep 2002;6:30-9.
69. Beck AT. Cognitive therapy and emotional disorders. Madison, CT: International Universities Press; 1976.
70. Klerman GL. Ideology and science in the individual psychotherapy of schizophrenia. Schizophr Bull 1984;10:608-12.
71. Watson CPN, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: A randomized trial. Neurology 1998; 51:1166-71.
72. Kishore-Kumar R, Max MB, Schafer SC, Gaughan AM, Smoller B, Gracely RH, Dubner R. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther 1990;47:305-12.
73. Richelson E. Pharmacology of antidepressants. Mayo Clin Proc 2001;76:511-27.
74. Fawcett J, Barkin RL. Efficacy issues with antidepressants. J Clin Psychiatry 1997;58(suppl 6):32-9.
75. Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001;178:234-41.
76. Greden JF. The burden of disease for treatment-resistant depression. J Clin Psychiatry 2001;62(suppl 16):26-31.
77. Richelson E. Treatment of acute depression. Psychiatr Clin North Am 1993;16:461-78.
78. Mulrow CD, Williams JW Jr, Chiquette E, Mulrow CD, Williams JW Jr, Chiquette E, Aguilar C, Hitchcock-Noel P, Lee S, Cornell J, Stamm K. Efficacy of newer medications for treating depression in primary care patients. Am J Med 2000;108: 54-64.
79. AHCPR. Depression in primary care: Detection and diagnosis. Detection and diagnosis clinical guideline. Rockville, MD: Agency for Healthcare Policy and Research; 1993.
80. Simon GE, Heiligenstein JH, Grothaus L, Katon W, Revicki D. Should anxiety and insomnia influence antidepressant selection: A randomized comparison of fluoxetine and imipramine. J Clin Psychiatry 1998;59:49-55.
81. Tollefson GD, Holman SL, Sayler ME, Potvin JH. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features. J Clin Psychiatry 1994;55:50-9.
82. Beasley CM Jr, Dornseif BE, Pultz JA, Bosomworth JC, Sayler ME. Fluoxetine versus trazodone: Efficacy and activating-sedating effects. J Clin Psychiatry 1991;52:294-9.
83. Simon GE, Heiligenstein J, Revicki D, Von Korff M, Katon W, Ludmon E, Grothaus L, Wagner E. Long-term outcomes of initial antideRressant drug choice in a "rEal world" randomized trial. Arch Fam Med 1999;8:319-25.
84. Markowitz JS, Patrick KS. Venlafaxine-tramadol similarities. Med Hypotheses 1998;51:167-8.
85. Tran PV, Bymaster FP, McNamara RK, Potter WZ. Dual monoamine modulation for improved treatment of major depressive disorder. J Clin Psychopharmacol. 2003;23:78-86.
86. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 1998;280:1837-42.
87. Brawman-Mintzer O. Pharmacologic treatment of generalized anxiety disorder. Psychiatr Clin North Am 2001;24:119-37.
88. Blier P, Abbott FV. Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain. J Psychiatry Neurosci 2001; 26:37-43.
89. Sasson Y, Zohar J, Chopra M, Lustig M, Iancu I, Hendler T. Epidemiology of obsessive-compulsive disorder: A world view. J Clin Psychiatry 1997;58 (suppl 12):7-10.
90. Bryant RA, Sackville T, Dang ST, Moulds M, Guthrie R. Treating acute stress disorder: An evaluation of cognitive behavior therapy and supportive counseling techniques. Am J Psychiatry 1999;156:1780-6.
91. Davidson J, Kudler H, Smith R, Mahorney SL, Lipper S, Hammett E, Saunders WB, Cavenar JO Jr. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry 1990;47:259-66.
92. van der Kolk BA, Dreyfuss D, Michaels M, Shera D, Berkowitz R, Fisler R, Saxe G. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 1994;55:517-22.
93. Davidson JR, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry 2001;58:485-92.
94. Kosten TR, Frank JB, Dan E, McDougle CJ, Giller EL Jr. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis 1991;179:366-70.
95. Connor KM, Sutherland SM, Tupler LA, Malik ML, Davidson JR. Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study. BrJ Psychiatry 1999;175:17-22.
96. Kirkwood CK, Hayes PE. Anxiety disorders. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy. Stamford: Appleton & Lange; 1997:1443-62.
97. Rickels K, Pollack MH, Sheehan DV, Haskins JT. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. Am J Psychiatry 2000;157:968-74.
98. Davidson JR. Pharmacotherapy of generalized anxiety disorder. J Clin Psychiatry 2001;62(suppl 11):46-50; discussion 51-2.
99. Feltner DE, Crockatt JG, Dubovsky SJ, Cohn CK, Shrivastava RK, Targum SD, Liu-Dumaw M, Carter CM, Pande AC. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J Clin Psychopharmacol 2003;23:240-9.
100. Pande AC, Crockatt JG, Feltner DE, Janney CA, Smith WT, Weisler R, Londborg PD, Bielski RJ, Zimbroff DL, Davidson JRT, Liu-Dumaw M. Pregabalin in generalized anxiety disorder: A placebo-controlled trial. Am J Psychiatry 2003;160:533-40.
101. Semenchuk MR, Sherman S, Davis B. Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology 2001;57:1583-8.
102. Allan L, Hays H, Jensen NH, de Waroux BL, Bolt M, Donald R, Kalso E. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001;322:1154-8.
103. Dworkin RH, Corbin AE, Young JP Jr, Sharma U, LaMoreaux L, Bockbrader H, Garofalo EA, Poole RM. Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2003;60:1274-83.
104. Moote CA, Knill RL, Skinner MI. Morphine disrupts nocturnal sleep in a dose dependent fashion. Anesth Analg 1989;68:S200.
105. Placidi F, Scalise A, Marciani MG, Romigi A, Diomedi M, Gigli GL. Effect of antiepileptic drugs on sleep. Clin Neurophysiol 2 000;111(suppl 2):S115-9.
106. Thase ME. Depression, sleep, and antidepressants. J Clin Psychiatry 1998;59(suppl 4):55-65.